SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses

Journal:

Nature Communications

Published:

2026-04-16

DOI:

10.1038/s41467-026-71662-y

Affiliations:

5

Authors:

15

Go to article

Institutions	Authors	Share
NIH NIAID Vaccine Research Center (VRC), United States of America (USA)	14.000000 14.000000	0.93
University of Washington (UW), United States of America (USA)	0.500000	0.03
Infectious Diseases Clinical Research Consortium (IDCRC), United States of America (USA)	0.250000	0.02
Fred Hutchinson Cancer Center, United States of America (USA)	0.250000	0.02

Interested in Clinical Sciences?